What is the Ownership and Shareholding Structure of Alembic Pharmaceuticals?
In 2023, Alembic Pharmaceuticals had a promoter holding of 69.61% and a public holding of 30.40%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.











Company Details
+91-XXXXXXXXXX